Compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality as finished products
And if anything else comes up in questions, reach out to us
Obesity is the most common chronic disease in the United States
Solutions and Innovations Development of Oral Formulations: Companies like Eli Lilly are focusing on oral GLP-1 drugs to improve patient adherence and convenience
Excess fat in the abdominal area, called visceral fat, contributes to major causes of death and disability, such as heart attacks, strokes, high blood pressure, some cancers, fatty liver disease, and type 2 diabetes
[Obesity] drives about 50% of the health care costs in this country, and increases our rates of diabetes and cardiac diseases, he said